Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA)

BACKGROUND: Both methotrexate (MTX) and leflunomide (LEF) are registered and regularly prescribed as first-line treatments for the use in patients with psoriatic arthritis (PsA) and they are occasionally used in combination. However, evidence about their individual, and especially combined efficacy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulder, Michelle L. M., Vriezekolk, Johanna E., den Broeder, Nathan, Mahler, Elien A. M., Helliwell, Philip S., van den Hoogen, Frank H. J., den Broeder, Alfons A., Wenink, Mark H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011519/
https://www.ncbi.nlm.nih.gov/pubmed/32041657
http://dx.doi.org/10.1186/s13063-020-4097-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011519/
https://www.ncbi.nlm.nih.gov/pubmed/32041657
http://dx.doi.org/10.1186/s13063-020-4097-6

Ejemplares similares